qRT-PCR demonstrated that the low levels of ALDH1A2 expression in ovarian cancer cell lines were reversed following treatment with the demethylation agent 5-Aza-CdR (Figure 2B). Here, ALDH1A2 is linked to ovarian carcinoma.